SLC5A2 and metabolic dysfunction-associated steatotic liver disease: 316 Raj Raj H H Durgia Durgia H H Palui Palui R R Kamalanathan Kamalanathan S S Selvarajan Selvarajan S S Kar Kar SS SS SGLT-2 Inhibitors in Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus: A Systematic Review SGLT-2 Inhibitors in Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus: A Systematic Review World J Diabetes World J Diabetes 2019 2019 10 10 2 2 114 114 132 132 10.4239/wjd.v10.i2.114 10.4239/wjd.v10.i2.114 30788048 30788048